Delisting risk
Hoth Therapeutics (HOTH)
Develops early-stage therapies for oncology, inflammatory, neurologic, dermatologic, and metabolic needs.
$0.8013
At close−0.02 (−2.22%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions19 holders · as of Mar 31, 2026 | ≥ 3.16% | 786.8K shares | |
| Insiders1 holder · as of Feb 23, 2022 | 0.15% | 36.5K shares | |
| Otherremainder | ≤ 96.69% | 24.07M shares |
24.90M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (24.90M in the company's Sep 3, 2026 report, 13.26M elsewhere); stakes use the report.
Institutional filings for RKTO (100% of the company) are not on file here, so the institutional figure is a floor.
Institutions13F, as of Mar 31, 2026
19 holders · 786.8K shares · 5 new positions · 9 increased · 2 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 214.2K | 0.86% | +33.1K | May 15, 2026 |
| UBS Group AG | 158.0K | 0.63% | +99.6K | May 5, 2026 |
| Vanguard Capital Management LLC | 129.7K | 0.52% | +129.7Knew | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 84.3K | 0.34% | +84.3Knew | May 8, 2026 |
| State Street Corp | 63.9K | 0.26% | 0 | May 15, 2026 |
| Northern Trust Corp | 42.1K | 0.17% | 0 | May 14, 2026 |
| Lido Advisors, LLC | 39.0K | 0.16% | +19.5K | May 13, 2026 |
| XTX Topco Ltd | 18.1K | 0.07% | +18.1Knew | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.